Replies to post #238320 on Biotech Values

[DewDiligence]

ASMB discontinues HBV core inhibitor, ABI-H2158 due_to_liver_tox:

https://www.globenewswire.com/news-release/2021/09/01/2290389/16259/en/Assembly-Bio-Announces-Decision-to-Discontinue-Clinical-Development-of-ABI-H2158.html

This company can’t seem to get anything right! Please see #msg-162149575, #msg-159327881 for background info.